H1.3 expression also did not correlate significantly with any of the other classical pathologic prognostic factors including tumor size, differentiation, lymph node metastasis, resection margin status, or receipt of adjuvant chemotherapy, which may mark this histone variant as a possible useful prognostic marker in the future. This evidence concerns the gene H1-3 and neoplasm.